Clinical Trials Browser

Phase 2/3 × Thalidomide × Other hematologic neoplasm × Clear all

NCT04453345 2020-07-01

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic